Details, Fiction and pharmaceutical ingredients and excipients
This marks the next development collaboration for The 2 events pursuing the announcement of the 1st plan on January 31, 2024, the place Willow has by now productively reached specified advancement targets.Procos. Procos, a Cameri, Italy-primarily based CDMO, is investing EUR 17 million ($19 million) to develop its existing HPAPI manufacturing facil